The Cancer Letter

Inside information on cancer research and drug development

In Brief

Crystal Rodriguez-Dabney named chief diversity officer and senior VP at Roswell Park

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Crystal Rodriguez-Dabney was named chief diversity officer and senior vice president, a senior leadership position with direct influence on initiatives across the organization, at Roswell Park Comprehensive Cancer Center. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Black patients who receive docetaxel for breast cancer experience less peripheral neuropathy than those who receive paclitaxel

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with docetaxel experience less peripheral neuropathy. Their findings represent an important shift in knowledge about a patient population who’ve historically been underrepresented in breast cancer research.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account